Annals of Oncology 2006 17(3):535; doi:10.1093/annonc/mdl032
© 2006 European Society for Medical Oncology
corrigendum |
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. Ann Oncol 2005; 16: 16391645
The following investigators need to be recognized in addition to the investigators for Taiwan already listed in the acknowledgements:
Dr. Jen-Shi Chen, Chang Gung Memorial Hospital, Taipei; Dr. Yee Chao, Taipei Veterans General Hospital, Taipei.
The authors apologize for erroneously omitting these names from the article.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||